|1.||Guzman-Aranguez, Ana: 1 article (01/2014)|
|2.||Diebold, Yolanda: 1 article (01/2014)|
|3.||Pintor, Jesús: 1 article (01/2014)|
|4.||Gasull, Xavier: 1 article (01/2014)|
|5.||Novak, Ivana: 1 article (04/2013)|
|6.||Wang, Jing: 1 article (04/2013)|
|7.||Haanes, Kristian A: 1 article (04/2013)|
|8.||Skeith, L: 1 article (02/2009)|
|9.||Barajas-Espinosa, A R: 1 article (02/2009)|
|10.||Neshat, S: 1 article (02/2009)|
|1.||Cystic Fibrosis (Mucoviscidosis)
11/01/2001 - "A dual role for purinergic agonists: closer to effective treatment for cystic fibrosis?"
04/01/2013 - "Purinergic agonists have been considered for the treatment of respiratory epithelia in cystic fibrosis (CF) patients. "
05/01/1994 - "The effects of purinoceptor agonists on Cl- secretion were examined in a transformed cystic fibrosis airway phenotype epithelial cell line, CFPEo-. "
01/01/2003 - "Pharmacotherapy of the ion transport defect in cystic fibrosis: role of purinergic receptor agonists and other potential therapeutics."
01/01/2014 - "This involvement suggests the possible use of purinergic agonists and antagonists as therapeutic targets for ocular inflammation. "
09/01/2008 - "The ability to inhibit release of inflammatory mediators induced in HMEC-1 cells by purinergic agonists may be a useful way to screen for potential therapeutic agents for cutaneous inflammation."
|4.||Stomach Ulcer (Gastric Ulcer)
|1.||Adenosine Triphosphate (ATP)
|6.||sodium sulfate (sodium bisulfate)
|2.||Drug Therapy (Chemotherapy)